This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Oxerutins oral

Updated 2 Feb 2023 | Peripheral vascular disease


Oral formulations of oxerutins.

Drugs List

  • oxerutins 250mg capsules
  • PAROVEN 250mg capsules
  • Therapeutic Indications


    Chronic venous insufficiency oedema: symptomatic relief



    500mg twice daily.


    Children under 18 years
    First trimester of pregnancy

    Precautions and Warnings

    Second trimester of pregnancy
    Third trimester of pregnancy

    Advise ability to drive/operate machinery may be affected by side effects
    Advise patient to consult physician if condition worsens / does not improve

    Treatment of leg oedema due to hepatic, renal or cardiac disease should be directed to the underlying cause. Oxerutins is not indicated for these conditions.

    Pregnancy and Lactation


    Oxerutins is contraindicated in the first trimester and should be used with caution in the second and third trimesters of pregnancy.

    Animal studies show no increase in teratogenic or other effects to the foetus if used in the recommended dosage during pregnancy.


    Use oxerutins with caution in breastfeeding.

    In animal studies traces of oxerutins and/or metabolites have been found in the breast milk but the levels are not considered to be of clinical relevance.

    Side Effects

    Abdominal pain
    Anaphylactoid reaction
    Gastro-intestinal disturbances
    Hypersensitivity reactions


    It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

    The following number will direct the caller to the relevant local centre (0844) 892 0111

    Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( ) or if this is unavailable at the backup site ( ).

    Further Information

    Last Full Review Date: August 2016

    Reference Sources

    Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. Accessed on 10 August 2016.

    Summary of Product Characteristics: Paroven capsules. Novartis Consumer Health. Revised July 2019.

    NICE Evidence Services Available at: Last accessed: 21 August 2019

    Access the full UK drug database with a FREE Medscape UK Account
    It takes just a few minutes, and you’ll get unlimited access to information on over 11,000 UK drugs.
    Register for Free

    Already a member? Log in

    Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content

    FDB Logo

    FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.